Gastroenterology remains ‘solid, steady’ investment option: 2 deals to know

Gastroenterology and urology remain steady investment opportunities in 2022, according to an Aug. 14 article in JDSupra from the law firm Bass, Berry & Sims. 

Read the full post on Becker's ASC